Vikas P. Sukhatme

41.3k total citations · 10 hit papers
249 papers, 32.8k citations indexed

About

Vikas P. Sukhatme is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Vikas P. Sukhatme has authored 249 papers receiving a total of 32.8k indexed citations (citations by other indexed papers that have themselves been cited), including 165 papers in Molecular Biology, 64 papers in Cancer Research and 34 papers in Oncology. Recurrent topics in Vikas P. Sukhatme's work include Angiogenesis and VEGF in Cancer (44 papers), Renal and related cancers (39 papers) and Cancer, Hypoxia, and Metabolism (38 papers). Vikas P. Sukhatme is often cited by papers focused on Angiogenesis and VEGF in Cancer (44 papers), Renal and related cancers (39 papers) and Cancer, Hypoxia, and Metabolism (38 papers). Vikas P. Sukhatme collaborates with scholars based in United States, United Kingdom and Belgium. Vikas P. Sukhatme's co-authors include S. Ananth Karumanchi, Andrea Gashler, Isaac E. Stillman, Leonidas Tsiokas, Franklin H. Epstein, Towia A. Libermann, Frank W. Sellke, Jaime R. Merchan, Sharon E. Maynard and Mohanraj Dhanabal and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Vikas P. Sukhatme

248 papers receiving 32.2k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia

2003 3.1k citations Sharon E. Maynard, Jaime R. Merchan et al. Journal of Clinical Investigation profile →
Circulating Angiogenic Factors and the Risk of Preeclampsia

2004 2.7k citations Vikas P. Sukhatme, S. Ananth Karumanchi et al. profile →
Soluble endoglin contributes to the pathogenesis of preeclampsia

2006 1.4k citations Jun‐ichi Hanai, Isaac E. Stillman et al. profile →
A zinc finger-encoding gene coregulated with c-fos during growth and differentiation, and after cellular depolarization

1988 1.2k citations Vikas P. Sukhatme et al. profile →
Co-assembly of polycystin-1 and -2 produces unique cation-permeable currents

2000 661 citations Vikas P. Sukhatme et al. profile →
Tumor-Derived Lactate Modifies Antitumor Immune Response: Effect on Myeloid-Derived Suppressor Cells and NK Cells

2013 631 citations Zaheed Husain, Pankaj Seth et al. profile →
Combined effects of angiostatin and ionizing radiation in antitumour therapy

1998 582 citations Mohanraj Dhanabal, Vikas P. Sukhatme et al. profile →
Early Growth Response Protein 1 (Egr-1): Prototype of a Zinc-finger Family of Transcription Factors

1995 530 citations Andrea Gashler, Vikas P. Sukhatme Progress in nucleic acid research and molecular biology profile →
Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation

1995 517 citations Vikas P. Sukhatme et al. profile →
Endostatin Induces Endothelial Cell Apoptosis

1999 502 citations Mohanraj Dhanabal, Vikas P. Sukhatme et al. Journal of Biological Chemistry profile →

Peers

Countries citing papers authored by Vikas P. Sukhatme

Since Specialization

Citations

This map shows the geographic impact of Vikas P. Sukhatme's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vikas P. Sukhatme with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vikas P. Sukhatme more than expected).

Fields of papers citing papers by Vikas P. Sukhatme

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vikas P. Sukhatme. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vikas P. Sukhatme. The network helps show where Vikas P. Sukhatme may publish in the future.

Co-authorship network of co-authors of Vikas P. Sukhatme

This figure shows the co-authorship network connecting the top 25 collaborators of Vikas P. Sukhatme. A scholar is included among the top collaborators of Vikas P. Sukhatme based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vikas P. Sukhatme. Vikas P. Sukhatme is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Why Certain Repurposed Drugs Are Unlikely to Be Effective Antivirals to Treat SARS-CoV-2 Infections 2024 ·Viruses ·Selwyn J. Hurwitz, (unknown), (unknown), (unknown), (unknown), Keivan Zandi, Tamara R. McBrayer, Franck Amblard, Dharmeshkumar Patel, James J. Kohler, Manoj Bhasin, Brian Dobosh, Vikas P. Sukhatme, Rabindra Tirouvanziam, Raymond F. Schinazi	3
2	The Association of Improved Overall Survival with NSAIDs in Non–Small Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors 2023 ·Clinical Lung Cancer ·Nikhil Sebastian, William Stokes, Madhusmita Behera, Renjian Jiang, David Gutman, (unknown), (unknown), Vidula Sukhatme, Michael Lowe, Suresh S. Ramalingam, Vikas P. Sukhatme, Drew Moghanaki	13
3	Baricitinib attenuates the proinflammatory phase of COVID-19 driven by lung-infiltrating monocytes 2022 ·Cell Reports ·Brian Dobosh, Keivan Zandi, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Junkai Yang, (unknown), Manoj Bhasin, Eliver Ghosn, Vikas P. Sukhatme, Raymond F. Schinazi, Rabindra Tirouvanziam	11
4	Citrate Suppresses Tumor Growth in Multiple Models through Inhibition of Glycolysis, the Tricarboxylic Acid Cycle and the IGF-1R Pathway 2017 ·Scientific Reports ·Jian-Guo Ren, Pankaj Seth, Huihui Ye, Kun Guo, Jun‐ichi Hanai, Zaheed Husain, Vikas P. Sukhatme	111
5	Repurposing Drugs in Oncology (ReDO)—chloroquine and hydroxychloroquine as anti-cancer agents 2017 ·ecancermedicalscience ·Ciska Verbaanderd, Hannelore Maes, Marco B.E. Schaaf, Vikas P. Sukhatme, Pan Pantziarka, Vidula Sukhatme, Patrizia Agostinis, Gauthier Bouche	203
6	ecancermedicalscience 2016 ·ecancermedicalscience ·Pan Pantziarka, Gauthier Bouche, Lydie Meheus, Vidula Sukhatme, Vikas P. Sukhatme, Praveen Vikas	145
7	Drug repurposing in oncology—patient and health systems opportunities 2015 ·Nature Reviews Clinical Oncology ·Francesco Bertolini, Vikas P. Sukhatme, Gauthier Bouche	226
8	Carbon Monoxide Expedites Metabolic Exhaustion to Inhibit Tumor Growth 2013 ·Cancer Research ·Barbara Wegiel, David Gallo, Eva Csizmadia, Clair Harris, John D. Belcher, Gregory M. Vercellotti, Nuno Penacho, Pankaj Seth, Vikas P. Sukhatme, Asif Ahmed, Pier Paolo Pandolfi, Leszek Helczynski, Anders Bjartell, Jenny L. Persson, Leo E. Otterbein	324
9	A phase 2 pilot trial of low‐dose, continuous infusion, or “metronomic” paclitaxel and oral celecoxib in patients with metastatic melanoma 2010 ·Cancer ·Rupal S. Bhatt, Jaime R. Merchan, Robert Parker, Hua‐Kang Wu, Liang Zhang, Virginia Seery, John V. Heymach, Michael B. Atkins, David F. McDermott, Vikas P. Sukhatme	57
10	Hypoxia‐inducible factor‐2α: effect on radiation sensitivity and differential regulation by an mTOR inhibitor 2008 ·British Journal of Urology ·Rupal S. Bhatt, Daniel M. Landis, Michael Zimmer, (unknown), Shaoyong Chen, Vikas P. Sukhatme, Othon Iliopoulos, (unknown), Glenn J. Bubley	24
11	A Critical Role for Calponin 2 in Vascular Development 2005 ·Journal of Biological Chemistry ·Jian Tang, Guang Hu, J Hanai, (unknown), Yanfeng Lin, Bo Zhang, Jenna L. Galloway, Nathan Bahary, (unknown), Bernard Thisse, Christine Thisse, Jian‐Ping Jin, Leonard I. Zon, Vikas P. Sukhatme	54
12	Preeclampsia: A renal perspective 2005 ·Kidney International ·S. Ananth Karumanchi, Sharon E. Maynard, Isaac E. Stillman, Franklin H. Epstein, Vikas P. Sukhatme	223
13	Synergy between angiostatin and endostatin 2000 ·Cancer Research ·Yumi Yokoyama, Mohanraj Dhanabal, Arjan W. Griffioen, Vikas P. Sukhatme, Sundaram Ramakrishnan	7
14	Fibrosis and angiogenesis 2000 ·Current Opinion in Nephrology & Hypertension ·Raghu Kalluri, Vikas P. Sukhatme	80
15	Expression and Function of the Leucine Zipper Protein Par-4 in Apoptosis 1997 ·Molecular and Cellular Biology ·Stephen F. Sells, Seong‐Su Han, Sumathi Muthukkumar, (unknown), Ricky W. Johnstone, Erwin R. Boghaert, David Gillis, Guohui Liu, Prakash Nair, (unknown), (unknown), Mark P. Mattson, Vikas P. Sukhatme, Stephen G. Zimmer, David P. Wood, J. William McRoberts, Yang Shi, Vivek M. Rangnekar	159
16	Early Growth Response Protein 1 (Egr-1): Prototype of a Zinc-finger Family of Transcription Factors breakdown → 1995 ·Progress in nucleic acid research and molecular biology ·Andrea Gashler, Vikas P. Sukhatme	530
17	A Novel Repression Module, an Extensive Activation Domain, and a Bipartite Nuclear Localization Signal Defined in the Immediate-Early Transcription Factor Egr-1 1993 ·Molecular and Cellular Biology ·Andrea Gashler, Sowmya Swaminathan, Vikas P. Sukhatme	60
18	The Egr Family of Nuclear Signal Transducers 1991 ·American Journal of Kidney Diseases ·Vikas P. Sukhatme	24
19	Expression of the early growth response 1 and 2 zinc finger genes during induction of monocytic differentiation. 1991 ·Journal of Clinical Investigation ·Surender Kharbanda, Takashi Nakamura, Richard M. Stone, Ralf Hass, Steven H. Bernstein, Rakesh Datta, Vikas P. Sukhatme, Donald Küfe	92
20	Gene for the human T cell differentiation antigen Leu-2/T8 is closely linked to the kappa light chain locus on chromosome 2. 1985 ·The Journal of Experimental Medicine ·Vikas P. Sukhatme, Amy Cheng Vollmer, Jan Erikson, Masaharu Isobe, Carlo M. Croce, J R Parnes	52

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact